ARCHIVES

Recombinant TSH Avoids Need To Stop Replacement Therapy

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

Pertuzumab Delays Progression In HER2-Positive Breast Cancer

August 26, 2011

NCI Hires Harold Freeman To Direct New Center For Study Of Health Disparities.

June 16, 2000

CPRIT Likely to Get Funding For Two Years; DePinho Announces Austerity Measures

May 17, 2013

Roferon A Application Marred By Mission Data, Protocol, Compliance

September 24, 1999

ASCO Annual Meeting Attendance Tops 25,000, Continuing Fast Growth.

May 18, 2001

Supreme Court Lets Stand Lower Court Ruling On AZT Patents

January 19, 1996